Insulin for Diabetes in Pregnancy (SUGAR) Study
This study is looking at how to best manage diabetes during pregnancy. Researchers want to see if taking insulin glargine (a long-acting insulin) once a day works as well as taking insulin glargine once a day plus insulin lispro (a fast-acting insulin) with each meal. You might be able to join if you are a woman between 18 and 50 years old, have type 2 diabetes or gestational diabetes (diabetes that develops during pregnancy) requiring insulin, and speak English or Spanish. The study will compare how well these two insulin plans control blood sugar and affect the health of babies after birth. The goal is to see if the once-daily insulin plan is just as effective as the current standard of care.
- Study design
- This is an interventional study planning to enroll 176 participants. It compares two different insulin treatment plans.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome will be measured from enrollment until delivery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
At a glance
Conditions
Where it's being run
2 sites across 2 statesStudy leadership
- Emily Rosenfeld, DO · PRINCIPAL_INVESTIGATOR · Rutgers Robert Wood Johnson Medical School
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Composite outcomeFrom enrollment to delivery
NICU admission, neonatal hyperglycemia, neonatal hypoglycemia, large for gestational age, shoulder dystocia, hyperbilirubinemia stillbirth, and neonatal death